Constantine S. Mihas
Dean joined GTCR in 2001 and is currently a Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to Delray Farms, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago.
Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in life sciences and medical devices. He is currently a Director of Albany Molecular, Cebatech, Cedar Gate Technologies, Dash, GreatCall, Maravai LifeSciences, Riverchase Dermatology, Regatta Medical, Rx30, Sotera, TerSera and XIFIN. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Cole-Parmer, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Devicor Medical Products, Ovation Pharmaceuticals, Managed Healthcare Associates and Polypore.
Dean's interest in the community is evident by his strong support of WBEZ Chicago Public Media, a non-commercial, public radio station financed primarily by listener contributions, where he serves as a board member and chair of the finance committee.